Yes this is what make Ovarian cancer so deadly - late diagnosis.
As much as I personally want to push the Ovarian program ahead as fast as possible, I would rather us do a few programs right, than a whole lot of programs badly. I am hopeful that as we expand and gain traction that opportunities will arise that allow us to advance the ovarian program - we are blessed with an amazing number of fantastic opportunities, but this means we have to make some very hard decisions as we can’t do everything we might want to do.
- Forums
- ASX - By Stock
- RAC
- Ann: Race AGM presentations and strategic update
Ann: Race AGM presentations and strategic update, page-184
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.47 |
Change
-0.055(3.61%) |
Mkt cap ! $250.5M |
Open | High | Low | Value | Volume |
$1.53 | $1.58 | $1.46 | $143.9K | 96.36K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 230 | $1.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.48 | 550 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 230 | 1.465 |
1 | 410 | 1.460 |
3 | 46800 | 1.450 |
2 | 25548 | 1.440 |
1 | 2046 | 1.420 |
Price($) | Vol. | No. |
---|---|---|
1.480 | 550 | 1 |
1.490 | 2470 | 1 |
1.535 | 2456 | 2 |
1.570 | 37690 | 1 |
1.575 | 2000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online